CN112535281A - Health food with functions of reducing blood pressure and blood sugar and preparation method thereof - Google Patents
Health food with functions of reducing blood pressure and blood sugar and preparation method thereof Download PDFInfo
- Publication number
- CN112535281A CN112535281A CN201910896668.1A CN201910896668A CN112535281A CN 112535281 A CN112535281 A CN 112535281A CN 201910896668 A CN201910896668 A CN 201910896668A CN 112535281 A CN112535281 A CN 112535281A
- Authority
- CN
- China
- Prior art keywords
- health food
- blood pressure
- blood
- blood sugar
- functions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 230000036772 blood pressure Effects 0.000 title claims abstract description 17
- 235000013402 health food Nutrition 0.000 title claims abstract description 16
- 230000006870 function Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 5
- 239000004615 ingredient Substances 0.000 claims description 5
- 230000009982 effect on human Effects 0.000 claims 1
- 231100000957 no side effect Toxicity 0.000 claims 1
- 235000009854 Cucurbita moschata Nutrition 0.000 abstract description 14
- 235000007319 Avena orientalis Nutrition 0.000 abstract description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract description 13
- 244000075850 Avena orientalis Species 0.000 abstract description 12
- 235000000832 Ayote Nutrition 0.000 abstract description 12
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 abstract description 12
- 235000013305 food Nutrition 0.000 abstract description 12
- 235000015136 pumpkin Nutrition 0.000 abstract description 12
- 235000007558 Avena sp Nutrition 0.000 abstract description 11
- 240000004244 Cucurbita moschata Species 0.000 abstract description 11
- 235000009419 Fagopyrum esculentum Nutrition 0.000 abstract description 11
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 7
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 7
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 7
- 235000013312 flour Nutrition 0.000 abstract description 7
- 239000000843 powder Substances 0.000 abstract description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract description 5
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract description 4
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract description 4
- 240000008620 Fagopyrum esculentum Species 0.000 abstract description 3
- 235000021307 Triticum Nutrition 0.000 abstract description 3
- 244000098338 Triticum aestivum Species 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 244000234609 Portulaca oleracea Species 0.000 abstract 2
- 240000001949 Taraxacum officinale Species 0.000 abstract 2
- 241000209763 Avena sativa Species 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 36
- 241000282414 Homo sapiens Species 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 206010020772 Hypertension Diseases 0.000 description 13
- 241000219304 Portulacaceae Species 0.000 description 12
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 241000219051 Fagopyrum Species 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 241000219122 Cucurbita Species 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000020354 squash Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 208000024806 Brain atrophy Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 206010067116 Carotid arteriosclerosis Diseases 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 235000009844 Cucumis melo var conomon Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 206010010164 Hypertension complications Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000009101 diabetic angiopathy Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- -1 pentosan Natural products 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028503 regulation of lipid metabolic process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001927 retinal artery Anatomy 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
A health food with blood pressure and blood sugar reducing functions and a preparation method thereof, the technical field of the health food comprises the following components: the invention relates to a health food with functions of reducing blood pressure and blood sugar, belonging to the technical field of food processing. The specific implementation mode is as follows: a health food with blood pressure and blood sugar lowering functions comprises the following raw materials: the feed additive comprises the components of wheat, oat, purslane, dandelion, salvia miltiorrhiza, pumpkin powder, lotus leaf, rhizoma polygonati, flour and food plant additives allowed by the state. Preparing materials: the proportion of each component in each 500 g of raw materials is as follows: buckwheat: 50 g of oat: 50 g of purslane: 100 g of dandelion: 15 g of salvia miltiorrhiza: 10 g of pumpkin powder: 50 g of lotus leaves: 10 g of rhizoma polygonati: 15 g of flour and 200 g of plant additive.
Description
The technical field is as follows:
the invention relates to a health food with functions of reducing blood pressure and blood sugar, belonging to the technical field of food processing.
The invention content is as follows:
according to incomplete statistics, clinical observation and research in recent 60 years since the last 60 years of the century have confirmed that patients with hypertension and diabetes in China have exceeded 2 hundred million people, wherein the prevalence rate of adults over 18 years is 18.8%, while the control rate of hypertension and diabetes in China only reaches about 6.1%, and patients grow at a high rate year by year and are younger and younger. Statistically, about 150 ten thousand premature deaths occur annually in the country due to elevated blood pressure and blood sugar. Approximately 300 million people die of cardiovascular and cerebrovascular diseases each year, and about 66 percent of people are related to hypertension. At present, the national annual treatment cost of the hypertension diabetes is about 400 hundred million yuan, and the hypertension diabetes accounts for 41 percent of the outpatient number of the chronic diseases, which is the top. Hypertension causes many acute and chronic complications (or called target organ damage), and the length of the disease course and the high and low blood pressure level of hypertension are related to the complication severity of hypertension: 1. cardiac complications such as cardiac hypertrophy, coronary heart disease, myocardial infarction, arrhythmia, heart failure, and the like; 2. cerebral complications such as carotid arteriosclerosis, stroke (cerebral hemorrhage, cerebral infarction), brain atrophy, senile dementia, etc.; 3. renal complications such as renal arteriosclerosis, proteinuria, impaired renal function and even uremia; 4. ocular complications such as retinal artery hemorrhage, blindness, etc. Some patients with hypertension have a wrong area, and many people think that hypertensive diabetics can stop taking medicines when the symptoms are not obvious or are temporarily asymptomatic, so that the blood pressure fluctuation is too large to cause cerebral apoplexy and heart failure. Hypertension and diabetes mellitus are chronic diseases which are continuously treated and need to be controlled for a long time. It is used for relieving pain of patients with diabetes and chronic hypertension. The functional food is developed according to the principle of homology of medicine and food, can integrally regulate the blood sugar and the blood pressure of a patient, can also strengthen the physique of the patient, correct the metabolic disturbance of sugar, protein and fat, and regulate the number or the affinity of insulin receptors so as to increase the sensitivity of target cells to insulin and resist insulin. Can be used for preventing and treating diabetes and hypertension complications. Is suitable for patients of all ages (such as pregnant women and children), and can be used as snack without any side effect.
The specific implementation mode is as follows:
a health food with blood pressure and blood sugar lowering functions comprises the following raw materials: buckwheat, oat, purslane, dandelion, salvia miltiorrhiza, pumpkin powder, lotus leaf, rhizoma polygonati, flour and food plant additives allowed by the state.
Brief introduction of major ingredients and function:
firstly, buckwheat:
buckwheat is named as: triticum Aestivum, rye, and Triticum Aestivum are annual herbaceous plants of Fagopyrum of Polygonaceae. Buckwheat has a very low gluten content and the major protein is globulin. The semen Fagopyri Esculenti contains essential amino acids with high content of lysine and low content of methionine, and the amino acid pattern can be complementary with that of main grains (such as semen Tritici Aestivi, semen Maydis, and rice with low content of lysine). The carbohydrates of buckwheat are mainly starch. Because the grains are fine, the product is easy to cook, digest and process compared with other cereals.
The efficacy and the effect are as follows:
the buckwheat is comprehensive in nutrition, is rich in high-activity medicinal components such as bioflavonoids, skin-enriching substances, sugar alcohols, D-chiro-inositol and the like, and has the functions of reducing blood sugar, blood fat and cholesterol, resisting oxidation and aging and removing free radicals. The buckwheat contains rich dietary fibers, which are called as the seventh nutrient of human beings, can promote gastrointestinal motility and relax bowels, has good effect on preventing constipation, can reduce blood sugar and blood fat, and has great significance on human health. Buckwheat contains rich vitamin E and vitamin B, and the vitamins are essential organic compounds for human body and play an important role in growth, development and metabolism of human body. Wherein nicotinic acid is a water-soluble vitamin necessary for human body, participates in lipid metabolism of human body, has effects of removing toxic substance, dilating blood vessel, and reducing cholesterol. Rutin, also known as vitamin P, is a member of vitamin family, can protect eyesight, soften blood vessel, reduce blood lipid of human body, effectively prevent cerebral hemorrhage, and has anti-inflammatory effect. The buckwheat contains various trace elements, and the magnesium can dissolve fibrin of a human body, dilate blood vessels and effectively reduce cholesterol; manganese is also one of the trace elements necessary for the human body.
Second, oat:
the oat has effects of reducing blood lipid, reducing blood sugar, and increasing satiety. The oat is hulled and ground into oatmeal with different sizes, or is softened and rolled into oat roll. The instant oatmeal after the instant treatment has a somewhat crumbly feel, but its original shape can be seen. In general, the more viscous the same amount of oats cooked, the better the health effect. The oat is finely processed into oatmeal, so that the oatmeal is more convenient to eat, the taste is improved, and the oatmeal becomes a popular health-care food. The dietary fiber has many biological effects beneficial to health, can reduce low-density lipoprotein of triglyceride, promote cholesterol excretion, prevent and treat diabetes, and is beneficial to reducing the occurrence of diabetic vascular complications; the medicine can relax bowels and drain, and is very helpful for patients with habitual constipation; oatmeal belongs to low-calorie food, is easy to cause satiety after eating, and has the effect of losing weight after long-term eating. In addition, the oat contains abundant vitamins B1, B2, E, folic acid and the like, and can improve blood circulation and relieve pressure brought by life and work; the contained minerals such as calcium, phosphorus, iron, zinc, manganese, etc. also have effects of preventing osteoporosis, promoting wound healing, and preventing anemia.
The efficacy and the effect are as follows:
the oat has the effects of reducing serum Total Cholesterol (TC), Triglyceride (TG) and beta-lipoprotein (beta-LP), has a certain effect of increasing serum high-density lipoprotein cholesterol (HDL-C), has a very obvious effect of reducing blood fat, and has better curative effect on secondary hypertriglyceridemia than primary. The mechanism of action, it is believed that about half of the lipid-lowering effect is due to the effect of the relatively high unsaturated fatty acid content of oats, and the other half is due to the non-fat fraction, mainly the non-starch polysaccharide. Therefore, the oat is an ideal food for reducing the primary cardiovascular diseases such as blood fat, atherosclerosis, coronary heart disease, cerebral apoplexy and the like in the clinical treatment and the population prevention and cure in the future.
Third, purslane:
purslane, also known as purslane, is an annual herb of the purslane family. The Chinese medicinal herb is named as longevity vegetable, is distributed in various places in China, grows on the roadside of the field, and can be eaten or used as medicines. The purslane has the functions of clearing away heat and toxic materials, inducing diuresis for treating stranguria and the like, has high nutritional value and medicinal value, and is called natural antibiotic. Purslane also contains more physiologically active substances and a large amount of unsaturated fatty acids, and has the functions of regulating nutrition and treating diseases.
The efficacy and the effect are as follows:
herba Portulacae has effects of clearing heat and detoxicating, dispelling blood and subsiding swelling, and can be used for treating dysentery with pus and blood, heat stranguria, bloody stranguria, leukorrhagia, carbuncle, malignant boil, erysipelas, etc. Generally, it is used in large dose with single ingredient, and because of its wide source, it is easy to pick up and fresh, and the curative effect is very good. For diarrhea and dysentery caused by damp-heat, about 200 g of fresh purslane can be used, and the purslane can be drunk all the time when decocted into tea. Or cleaning with clear water, and juicing for administration. The effective components are retained to the maximum extent, so that the preparation has rapid action. Purslane contains a large amount of protein, fat, sugar, crude fiber and various nutritional ingredients such as calcium, phosphorus, iron and the like, and is rich in norepinephrine and potassium salt. Norepinephrine can promote insulin secretion, regulate sugar metabolism in human body, and has effects of reducing blood glucose concentration and keeping blood glucose stable; potassium salt can reduce blood pressure, slow heart rate, and protect heart. The purslane also contains a large amount of anti-aging effective components such as vitamin E, vitamin C, carotene, glutathione and the like, and can prevent platelet aggregation, coronary spasm and thrombosis after being eaten for a long time, thereby effectively preventing coronary heart disease. In addition, the purslane has strong inhibition effect on various bacteria such as dysentery bacillus, colon bacillus, staphylococcus aureus and the like, and is a name of natural antibiotics.
Fourthly, dandelion:
herba Taraxaci, also called GUGUGUDING, herba Veronicae Didyma, HUANGMIAO, HUANGDIDIDING, and herba Saxifragae, which are perennial herb plants of Taraxacum of Compositae. The dandelion tea is prepared from chopped and dried root or leaf, is rich in vitamins and minerals, and has effects of strengthening liver and reducing cholesterol.
The efficacy and the effect are as follows:
has antiviral, antibacterial, antiinflammatory, gastric ulcer resisting, liver protecting, gallbladder function promoting, bile discharging into intestine promoting, and immunity improving effects. It can be used for treating acute mastitis, lymphadenitis, acute conjunctivitis, fever, common cold, acute pharyngitis, tonsillitis, acute upper respiratory infection, bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
And fifthly, salvia miltiorrhiza:
the efficacy and the effect are as follows:
1. compendium of materia Medica: promoting blood circulation, dredging heart, and treating hernia pain.
2. The book Jing: pathogenic factors in the heart and abdomen, faint bowel movement, cold and heat accumulation, obstruction and removal of the abdominal mass, restlessness and fullness, and qi tonification.
3. The bibliography: nourishing blood, removing heart-abdomen pertinacious disease and qi stagnation, strengthening waist and back and foot arthralgia, removing pathogenic wind and retaining heat, and benefiting people after long-term administration.
Has the effects of activating blood circulation to dissipate blood stasis, stimulating the menstrual flow to relieve pain, clearing away the heart-fire and relieving restlessness, cooling blood and eliminating carbuncle. Can be used for treating thoracic obstruction, heart pain, abdominal pain, hypochondriac pain, abdominal mass, pain due to pyretic arthralgia, vexation, insomnia, menoxenia, dysmenorrhea, amenorrhea, and pyocutaneous disease with swelling and pain.
Sixthly, pumpkin powder:
pumpkin is an annual sprawl plant of cucurbitaceae cucurbita, which is also called: pumpkin, sweet melon, squash, rice melon, squash, etc. Experts believe that pumpkins span six steps across the food service: staple food, vegetables and fruits, exotic food, beverage and health food, and pharmacological food. Contains various amino acids, carotene, D vitamins, vitamin E, ascorbic acid, trigonelline, adenine, fat, glucose, pentosan, mannitol, etc., and also contains part of organic acids, inorganic salts, xanthophyll, phylline, pectin, enzyme, etc. The pumpkin powder is prepared by processing pumpkin, contains rich carbohydrate, protein, dietary fiber, vitamin, carotene, pectin, potassium, iron, magnesium and other rich trace elements, and is beneficial to human bodies by citrulline, arginine and other enzymes, but has very low fat content. People pay attention to their pumpkin diet with new feelings and sights.
The efficacy and the effect are as follows:
pumpkin contains rich cobalt, has important effects on protein, fat, carbohydrate metabolism and hemoglobin synthesis, and can dilate blood vessels and reduce blood pressure. In addition, cobalt can activate metabolism of human body, promote hematopoiesis, participate in the synthesis of vitamin B12 in human body, is a necessary microelement for human islet cells, and has special curative effects on preventing and treating diabetes and reducing blood sugar. The pectin in the pumpkin powder can delay the absorption of sugar and lipid by intestinal tracts, neutralize and remove heavy metals and partial pesticides in vivo, and can help patients with weakened liver and kidney functions to enhance the regeneration capacity of liver and kidney cells.
Seventhly, lotus leaf:
the efficacy and the effect are as follows:
the lotus leaf has the effects of relieving summer heat, promoting diuresis, strengthening spleen, invigorating yang, removing blood stasis and stopping bleeding, and is mainly used for treating summer heat, polydipsia, headache, dizziness, edema, anorexia, abdominal distension, diarrhea, leucorrhea, rectocele, hematemesis, epistaxis, hemoptysis, hematochezia, metrorrhagia, postpartum lochiorrhea and injury blood stasis, and has the effects of protecting liver, resisting hepatic fibrosis and the like. The action of losing weight and reducing blood lipid is recorded in Ben Cao gang mu, that is, the lotus leaf is thin and bad. The lotus leaf extract can reduce the digestion capacity of the body, reduce the absorption of lipid and carbohydrate and strengthen the regulation of lipid metabolism and energy loss, thereby effectively resisting obesity.
Eight, sealwort:
also named as tiger ginger and cockscomb ginseng. Rhizome of Liliaceae herbaceous plant rhizoma Polygonati, rhizoma Polygonati Yunnanensis, and rhizoma Polygonati Odorati. Once honored by Li, it is known as a "treasure medicine", which can not only treat various diseases, but also be a health food for all people.
The efficacy and the effect are as follows:
[ PROPERTIES AND FLAVOUR GUIDING CHANNEL ] is sweet and neutral. It enters lung, spleen and kidney meridians. [ FUNCTIONS ] can nourish kidney, moisten lung, invigorate spleen and replenish qi. Rhizoma Polygonati has effects of invigorating spleen, moistening lung, invigorating qi, nourishing yin, promoting fluid production, quenching thirst, and is sweet in taste, mild in nature, and easily accepted by weak people, and is suitable for patients with spleen and stomach deficiency cold, asthenia, listlessness, lung dryness, dry cough, diabetes and sexual impotence. Has therapeutic effect on diabetes. Rhizoma Polygonati has effects of lowering blood pressure, inhibiting hyperglycemia, and preventing and treating atherosclerosis and liver fat infiltration. According to the introduction of data, the sealwort is used as a main drug and is matched with other traditional Chinese medicinal materials, so that the medicine has obvious curative effects on treating pulmonary tuberculosis hemoptysis, coronary heart disease, angina, lung dryness, dry cough, whooping cough and the like. Raw Huang Jing has a numb taste, although it is not toxic, it usually does not penetrate the throat directly. The sealwort written in the prescription refers to the prepared sealwort.
Ninth, flour:
the wheat is ground into flour, also called wheat flour. The flour contains nutrients such as starch, protein, fat, vitamins, and minerals, and has effects in nourishing heart, invigorating kidney, invigorating spleen, strengthening intestine, removing heat, and quenching thirst.
Claims (3)
1. A health food with blood pressure and blood sugar reducing functions and a preparation method thereof are characterized in that: most of the ingredients used in the health food are medicinal and edible materials, have no side effect on human bodies, and play a key role in reducing blood pressure and blood sugar.
2. A health food with blood pressure and blood sugar reducing functions and a preparation method thereof are characterized in that: the proportion of the ingredients used in the health food is within the safety range of daily consumption of people.
3. A health food with blood pressure and blood sugar reducing functions and a preparation method thereof are characterized in that: the preparation method of the health food adopts the grinding of the dry materials, and the prepared product can adopt various modes and can play the roles of reducing blood pressure and blood sugar.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910896668.1A CN112535281A (en) | 2019-09-23 | 2019-09-23 | Health food with functions of reducing blood pressure and blood sugar and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910896668.1A CN112535281A (en) | 2019-09-23 | 2019-09-23 | Health food with functions of reducing blood pressure and blood sugar and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112535281A true CN112535281A (en) | 2021-03-23 |
Family
ID=75012936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910896668.1A Pending CN112535281A (en) | 2019-09-23 | 2019-09-23 | Health food with functions of reducing blood pressure and blood sugar and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112535281A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104115950A (en) * | 2014-05-15 | 2014-10-29 | 王腾鉴 | Tea with functions of reducing blood fat, blood pressure and blood glucose |
CN104206575A (en) * | 2014-07-04 | 2014-12-17 | 方向明 | Health-caring tea capable of reducing blood pressure, blood fat and blood glucose and preventing hypertension, hyperlipoidemia and hyperglycemia and preparation method thereof |
CN105533446A (en) * | 2016-02-03 | 2016-05-04 | 桂林西麦生物技术开发有限公司 | Nutritious oatmeal with health-care effect and preparation method thereof |
CN106343413A (en) * | 2016-08-26 | 2017-01-25 | 辽宁好护士生物科技有限公司 | Health food for assisting reduction of blood glucose, blood pressure and blood lipid |
CN112471300A (en) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | Formula and preparation method of medicinal and edible herbal tea capable of reducing blood pressure, blood fat and blood sugar |
-
2019
- 2019-09-23 CN CN201910896668.1A patent/CN112535281A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104115950A (en) * | 2014-05-15 | 2014-10-29 | 王腾鉴 | Tea with functions of reducing blood fat, blood pressure and blood glucose |
CN104206575A (en) * | 2014-07-04 | 2014-12-17 | 方向明 | Health-caring tea capable of reducing blood pressure, blood fat and blood glucose and preventing hypertension, hyperlipoidemia and hyperglycemia and preparation method thereof |
CN105533446A (en) * | 2016-02-03 | 2016-05-04 | 桂林西麦生物技术开发有限公司 | Nutritious oatmeal with health-care effect and preparation method thereof |
CN106343413A (en) * | 2016-08-26 | 2017-01-25 | 辽宁好护士生物科技有限公司 | Health food for assisting reduction of blood glucose, blood pressure and blood lipid |
CN112471300A (en) * | 2020-11-24 | 2021-03-12 | 南京博医源健康信息咨询有限公司 | Formula and preparation method of medicinal and edible herbal tea capable of reducing blood pressure, blood fat and blood sugar |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104171985A (en) | Composite nutrition-balanced healthy sprout food | |
CN111109602A (en) | Medicated functional food suitable for people with diabetes and hyperlipidemia obesity | |
CN103609992A (en) | Preparation method of Korean red ginseng cream | |
CN109588452A (en) | Safe and reliable nutrition-balanced nourishing class vegetables vegetarian diet is dry and preparation method thereof for refreshment | |
CN106937741A (en) | A kind of degreasing linseed meal cancer-resisting health slimming method and preparation method thereof | |
CN101755878B (en) | Preparation method of weight-reducing cake containing balsam pear, hawthorn and cassia seeds | |
CN112791175A (en) | Chinese and western medicine composition for improving human body metabolism function and discharging metabolic waste and preparation method thereof | |
CN111110792A (en) | Rhizoma polygonati and ginseng tea for controlling sugar, regulating lipid, reducing viscosity, preventing and treating diabetes and complications thereof | |
CN104431125A (en) | Sea-buckthorn honey tea and preparation method thereof | |
CN111249410A (en) | Medicated diet beverage for protecting liver, removing toxicity, discharging fat, preventing and treating liver injury and recovering liver function | |
CN110583943A (en) | Solid beverage for regulating blood sugar | |
CN112535281A (en) | Health food with functions of reducing blood pressure and blood sugar and preparation method thereof | |
CN110574916A (en) | nutritional meal replacement product with fat reducing and bowel relaxing effects and preparation method thereof | |
CN113080347A (en) | Herbal beverage for improving digestive system of human body and preparation method thereof | |
CN112568346A (en) | Health beverage with blood pressure lowering, blood sugar lowering and blood fat reducing effects | |
CN112294925A (en) | A medicine for treating gout, gastropathy and constipation, and its preparation method | |
CN110679935A (en) | Burdock and ginseng essence cream and preparation method thereof | |
CN110651983A (en) | High-protein nutrition powder and preparation method thereof | |
CN104623224A (en) | Externally applied traditional Chinese medicine composition for treating infantile malnutrition and application thereof | |
CN1102555A (en) | Sand pear beverage | |
CN104188036A (en) | Formula of plant beverage | |
CN107582735A (en) | A kind of black tea drink for nursing one's health phlegm-dampness constitution | |
CN115153017A (en) | Breakfast mate for tonifying kidney, strengthening spleen, clearing lung and beautifying, and preparation process and drinking method thereof | |
CN105582396A (en) | Weight reducing healthcare product | |
CN105595336A (en) | Preparation method of radix ginseng rubra and fructus lycii cell-wall breaking ultra-fine powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |